January is National Thyroid Month


  Thursday, January 27, 2022
  Community

By Karen Villarreal

RIO GRANDE VALLEY, TEXAS – Research and data show that early detection of conditions caused by the thyroid gland can be imperative, as those conditions can worsen slowly over time. 

January is National Thyroid Month, and doctors at UT Health RGV have been encouraging the Rio Grande Valley population – where rates of thyroid disease are high ­– to be vigilant and not put off diagnosis and treatment.  

Area doctors say that, for the Rio Grande Valley and Texas as a whole, the number of thyroid-related cancers is cause for concern.

  • Data from the American Cancer Society projects Texas will have the second-highest number of estimated new cases in 2022, with 3,490, behind California with 4,990.
  • Data also projects Texas will have the third-highest number of estimated deaths from thyroid cancer this year, with 150, behind California’s 310 and Florida’s 160.  
  • In Hidalgo and Willacy counties, the invasive cancer incidence rate is 12 per 100,000, slightly higher than the Texas rate of 11.7 per 100,000.
  • In Texas, the incidence rate for thyroid cancers differs by gender, with women at 17.5 percent, and men substantially lower at 6.3 percent. The rate for women in Cameron County was 18.6 percent, and 19 percent in Hidalgo County. Information on the rate for men in Cameron and Hidalgo counties was not available.
  • In the McAllen-Edinburg-Mission Metropolitan Statistical Area, according to the Texas Cancer Registry, 74 of 93 new cases last year were women, with six expected deaths. 
    The Brownsville-Harlingen MSA had 47 new cases, 75 percent of which were women, and two deaths. 

 

DETECTION & TREATMENT

Dr. Henry Reinhart
Dr. Henry Reinhart, UT Health RGV endocrine surgeon, is the only board-certified, fellowship-trained endocrine surgeon in the area. He is the only physician in the Mid- and Lower-Valley areas now treating certain thyroid conditions with radio frequency ablation, a new and leading edge treatment modality. (Photo by UTRGV School of Medicine)

UT Health RGV’s Dr. Henry Reinhart – the only board-certified, fellowship-trained endocrine surgeon in the area – also is the only physician in the Mid- and Lower-Valley areas now treating certain thyroid conditions with radio frequency ablation, a new and leading edge treatment modality.

Reinhart, MD, FACS, said he sees, on average, 40 patients a month at UT Health RGV for thyroid problems.  

“The thyroid is a small, butterfly-shaped gland in the neck, and it regulates the production of hormones that are involved with body temperature, digestion and other body processes,” he said. “People may not realize the severity of the issue. Left untreated, thyroid disease can be devastating to the heart and other organs.”  

When the thyroid gland is producing too much or too little hormone, the patient has hypo- or hyper-thyroid issues, which sometimes can be managed with medication. 

The first line of detection of thyroid problems is a TSH test, which may be followed by a neck ultrasound. 

Large nodules can also be present around the thyroid gland – both cancerous and benign – which can make it hard to swallow or breathe and can cause voice changes. 

“If they do have a thyroid nodule, they may need a biopsy to identify if it’s cancerous,” Reinhart said.  

Some patients require additional treatment, surgery, or simply want the nodules reduced for cosmetic reasons.  

THE LEADING EDGE  

Radio frequency ablation (RFA) is the fastest way to shrink large nodules without more invasive surgery, Reinhart said. 

“Patients who don’t want – or can’t have – surgery may experience relief from their symptoms via RFA treatment,” he said.  

During RFA, a needle is inserted, and radio waves generate heat to shrink the nodule, allowing the tissue around it to be carefully preserved. 

Overall, thyroid surgery can be technically challenging, Reinhart said, but very rewarding. 

“It takes a special set of hands,” he said. “I like that I can help people have a long, full life.” 

 

ULTRASOUND 

Dr. Rachel Giese
Dr. Rachel Giese, UT Health RGV Otolaryngologist (ENT), Laryngologist, Head & Neck Cancer surgeon, specializes in diagnosing patients with thyroid issues using medical tools like ultrasound. (Photo by UTRGV School of Medicine)

In addition to Reinhart, UT Health RGV’s Dr. Rachel Giese, MD, specializes in diagnosing patients with thyroid issues using medical tools like ultrasound.   

Giese, an otolaryngologist (ENT) and head and neck cancer surgeon, said ultrasound of the thyroid gland helps them identify and biopsy nodules.  

“Many patients have thyroid nodules and never realize it. In most cases that is fine because most thyroid nodules are not cancerous,” she said. 

“As a specialist, I like having a thyroid ultrasound in office because I can examine the patient myself. And ultrasound images help us show patients their own nodules,” she said. “Pictures make things clearer than an explanation alone.”

ABOUT UTRGV

The University of Texas Rio Grande Valley (UTRGV) was created by the Texas Legislature in 2013 as the first major public university of the 21st century in Texas. This transformative initiative provided the opportunity to expand educational opportunities in the Rio Grande Valley, including a new School of Medicine, and made it possible for residents of the region to benefit from the Permanent University Fund – a public endowment contributing support to the University of Texas System and other institutions.

UTRGV has campuses and off-campus research and teaching sites throughout the Rio Grande Valley including in Boca Chica Beach, Brownsville (formerly The University of Texas at Brownsville campus), Edinburg (formerly The University of Texas-Pan American campus), Harlingen, McAllen, Port Isabel, Rio Grande City, and South Padre Island. UTRGV, a comprehensive academic institution, enrolled its first class in the fall of 2015, and the School of Medicine welcomed its first class in the summer of 2016.